SIStockInvestingSI.com

NYSE · STE · Medical Devices

STERIS plc (Ireland) (STE) stock analysis

$221.48−1.64%Data as of Oct 21, 2026
  • STE gained 6.1% over the past month versus 0.0% for the S&P 500, ranking 153rd of 497 S&P 500 stocks.
  • Over 12 months it returned −8.3%, 24.1 points behind the S&P 500, and trades 17.3% below its 52-week high.
  • In the last 30 days 6 analysts raised earnings estimates and 0 cut; forward EPS moved +0.2% (+0.7% over 90 days).
  • It sits in the Supplies, sterilization & packaging segment of the Medtech, Diagnostics & Care, where the 1-month median return is +6.0%.
  • The daily chart reads Trend transition · Trend repair (since Oct 15, 2026).
Market cap$21.6B
12-month return−8.3%
Forward P/E18.1×
Mean target vs price+18.8%

One-year price with 50- and 200-day averages

Open in Hub
205224244263JanAprJulOct
221.4850-day200-day

Performance vs the market

Total price return against the S&P 500 (SPY) and the median of US stocks in the same sector.

STE+6.1%
Sector median−8.7%
S&P 5000.0%
STE+5.1%
Sector median−5.4%
S&P 500+4.7%
STE−0.9%
Sector median−1.5%
S&P 500+8.7%
STE−8.3%
Sector median+1.7%
S&P 500+15.8%
1-month rank in the S&P 500153 / 497
3-month rank in its sector · Healthcare254 / 720

Chart structure

Read by our daily-bar structure engine from swing highs, swing lows and moving averages.

Trend transition · Trend repairAwaiting confirmation

Holding since Oct 15, 2026

  • Price and averages have mixed alignment
  • EMA50 rose over the last ten sessions
  • Volume exceeds 1.5× the prior 20-session average; supporting evidence only
  • Intermediate and long-term directions differ
  • Neither a stable trend nor a range is confirmed
This pattern on this stock

42 occurrences in 10 years. The median move over the next 20 sessions was +2.3%, positive 69% of the time, against +1.3% for any day in the same period.

Reference zone, stop and targets for this structureSee the trade plan in Hub ↗

Analyst earnings revisions

Changes to the consensus forward-EPS estimate. Rising estimates mean analysts see more profit ahead.

Forward EPS$12.27
30-day change+0.2%
90-day change+0.7%
Mean target$263.13 +18.8%
Raised (30d) 6Cut (30d) 0

8 analysts cover the stock

Where it sits in the supply chain

Medtech, Diagnostics & Care · Devices, supplies & tests

Explore the full chain map in Hub
Its segment
Supplies, sterilization & packaging+6.0%
BDX+6.2%1 monthWST+6.0%1 monthSOLV−2.3%1 monthBAX+4.3%1 monthSTE+6.1%1 month

Supplies, infection control and packaging serve different medical settings.

Sells into
Hospitals & dialysis+2.0%
HCA+4.9%1 monthUHS+2.0%1 monthDVA−3.8%1 month
Medical & dental distribution−2.8%
HSIC−2.8%1 month

Figures are each company's 1-month return; the segment shows its median · Doubler daily batch · company chain maps

Risk profile

Max drawdown, 12M−25.6%
Volatility, 60D19.1%
From 52-week high−17.3%
From 52-week low+11.1%
Trailing P/E27.1×
Forward P/E18.1×

Themes

  • MedTech3M rank 39 / 90
BDXBecton, Dickinson and CompanyWSTWest Pharmaceutical Services, ISOLVSolventum CorporationBAXBaxter International Inc.UHSUniversal Health Services, Inc.DVADaVita Inc.HSICHenry Schein, Inc.ABTAbbott Laboratories

Track this stock every day

Hub adds the daily brief, StockFlow factor flow, trade plans and alerts for your watchlist.

Open in Hub ↗